RENAL OUTCOMES IN POST-LIVER TRANSPLANT RECIPIENTS TREATED WITH TENOFOVIR ALAFENAMIDE COMPARED WITH TENOFOVIR DISOPROXIL FUMARATE AND ENTECAVIR

被引：0

作者：

Liu, Joanne ^{[1
]}

Vutien, Philip ^{[2
]}

Huang, Daniel ^{[3
,4
]}

Ishigami, Masatoshi ^{[5
]}

Daniel, Peter Chen Yang Nikhil ^{[6
]}

Ito, Takanori ^{[5
]}

Dang, Hansen ^{[7
]}

Maeda, Mayumi ^{[7
]}

Leong, Jennifer ^{[8
]}

Landis, Charles ^{[9
]}

Nguyen, Mindie H. ^{[7
]}

机构：

[1] Univ Washington, Seattle, WA 98195 USA

[2] Univ Washington, Div Gastroenterol, Seattle, WA 98195 USA

[3] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore

[4] Natl Univ Singapore Hosp, Div Gastroenterol & Hepatol, Singapore, Singapore

[5] Nagoya Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, Nagoya, Aichi, Japan

[6] Natl Univ Singapore Hosp, Dept Med, Singapore, Singapore

[7] Stanford Univ, Med Ctr, Div Gastroenterol & Hepatol, Stanford, CA 94305 USA

[8] Icahn Sch Med Mt Sinai, Dept Med, Div Liver Dis, Recanati Miller Transplantat Inst, New York, NY 10029 USA

[9] Univ Washington, Div Gastroenterol & Hepatol, Seattle, WA 98195 USA

来源：

HEPATOLOGY | 2021年 / 74卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

802

引用

页码：492A / 493A

页数：2

共 50 条

[21] Converting from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in Patients with Hepatitis B Following Liver Transplantation
Cheng, Chih-Hsien
Hung, Hao-Chien
Lee, Jin-Chiao
Wang, Yu-Chao
Wu, Tsung-Han
Lee, Chen-Fang
Wu, Ting-Jung
Chou, Hong-Shiue
Chan, Kun-Ming
Lee, Wei-Chen
ANNALS OF TRANSPLANTATION, 2023, 28
[22] Safety of Tenofovir Alafenamide in People With HIV Who Experienced Proximal Renal Tubulopathy on Tenofovir Disoproxil Fumarate
Campbell, Lucy
Barbini, Birgit
Burling, Keith
Cromarty, Ben
Hamzah, Lisa
Johnson, Margaret
Jones, Rachael
Samarawickrama, Amanda
Williams, Deborah
Winston, Alan
Post, Frank A.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2021, 88 (02) : 214 - 219
[23] Treatment and Renal Outcomes Up to 96 Weeks After Tenofovir Alafenamide Switch From Tenofovir Disoproxil Fumarate in Routine Practice
Toyoda, Hidenori
Leong, Jennifer
Landis, Charles
Atsukawa, Masanori
Watanabe, Tsunamasa
Huang, Daniel Q.
Liu, Joanne
Quek, Sabrina Xin Zi
Ishikawa, Toru
Arai, Taeang
Yokohama, Keisuke
Chuma, Makoto
Takaguchi, Koichi
Uojima, Haruki
Senoo, Tomonori
Dang, Hansen
Maeda, Mayumi
Hoang, Joseph
Le, Richard H.
Yasuda, Satoshi
Thin, Khin N.
Tran, Sally
Chien, Nicholas
Henry, Linda
Asai, Akira
Fukunishi, Shinya
Cheung, Ramsey
Lim, Seng Gee
Trinh, Huy N.
Nguyen, Mindie H.
HEPATOLOGY, 2021, 74 (02) : 656 - 666
[24] Tenofovir alafenamide as compared to tenofovir disoproxil fumarate in the management of chronic hepatitis B with recent trends in patient demographics
Hsu, Yao-Chun
Wei, Mike T.
Nguyen, Mindie H.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 11 (11) : 999 - 1008
[25] THE EFFECT OF TENOFOVIR DISOPROXIL FUMARATE USE ON BONE MINERAL DENSITY IN LIVER TRANSPLANT RECIPIENTS
Turan, Ilker
Celik, Ferit
Uysal, Alper
Senkaya, Ali
Durmazer, Esra Nur Nur
Zeytunlu, Murat
Gunsar, Fulya
Karasu, Zeki
Akarca, Ulus S.
HEPATOLOGY, 2023, 78 : S347 - S347
[26] Comparison of body weight and lipid profiles following tenofovir disoproxil fumarate or entecavir switching to tenofovir alafenamide-an interim analysis
Cheng, Pin-Nan
Liu, Chun-Jen
Chen, Jyh-Jou
Feng, I-Cher
Kuo, Hsing-Tao
Lee, Pei-Lun
Yu, Ming-Lung
Chiu, Yencheng
Hung-Chih, Chiu
Chien, Shih-Chieh
Chen, Pei-Jer
JOURNAL OF HEPATOLOGY, 2022, 77 : S863 - S864
[27] THE EFFECTS OF ENTECAVIR, TENOFOVIR DISOPROXIL FUMARATE, AND TENOFOVIR ALAFENAMIDE ON THE PROGNOSIS OF TREATMENT-NAIVE PATIENTS WITH CHRONIC HEPATITIS B INFECTIONS
Chon, Hye Yeon
Chun, Ho Soo
Lee, Jae Seung
Lee, Hye Won
Kim, Beom Kyung
Park, Jun Yong
Kim, Do Young
Ahn, Sang Hoon
Sinn, Dong Hyun
Lee, Jeong-Hoon
Kim, Seung Up
HEPATOLOGY, 2020, 72 : 498A - 498A
[28] RENAL OUTCOMES IN CHRONIC HEPATITIS B PATIENTS TREATED WITH TENOFOVIR DISOPROXIL FUMARATE OR ENTECAVIR: A PROPENSITY SCORE MATCHED STUDY
Trinh, Sam
Le, An K.
Hoang, Joseph
Jeong, Donghak
Chung, Mimi
Lee, Mei-Hsuan
Wang, Uerica
Nguyen, Mindie H.
GASTROENTEROLOGY, 2018, 154 (06) : S1081 - S1081
[29] Renal outcomes in chronic hepatitis b patients treated with tenofovir disoproxil fumarate or entecavir: a propensity score matched study
Trinh, S.
Le, A.
Hoang, J.
Jeong, D.
Chung, M.
Lee, M. -H.
Wang, U.
Nguyen, M.
JOURNAL OF HEPATOLOGY, 2018, 68 : S519 - S520
[30] Reply to correspondence on "Cardiovascular risk in chronic hepatitis B patients treated with tenofovir disoproxil fumarate or tenofovir alafenamide"
Cheng, Pin-Nan
Yu, Ming-Lung
CLINICAL AND MOLECULAR HEPATOLOGY, 2024, 30 (04)

← 1 2 3 4 5 →